Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Béziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, Staal J, Aschenbrenner D, Roels L, Worley L, Claes K, Gartner L, Kohn LA, De Bruyne M, Schmitz-Abe K, Charbonnier LM, Keles S, Nammour J, Vladikine N, Maglorius Renkilaraj MRL, Seeleuthner Y, Migaud M, Rosain J, Jeljeli M, Boisson B, Van Braeckel E, Rosenfeld JA, Dai H, Burrage LC, Murdock DR, Lambrecht BN, Avettand-Fenoel V, Vogel TP; Undiagnosed Diseases Network, Esther CR, Haskologlu S, Dogu F, Ciznar P, Boutboul D, Ouachée-Chardin M, Amourette J, Lebras MN, Gauvain C, Tcherakian C, Ikinciogullari A, Beyaert R, Abel L, Milner JD, Grimbacher B, Couderc LJ, Butte MJ, Freeman AF, Catherinot É, Fieschi C, Chatila TA, Tangye SG, Uhlig HH, Haerynck F, Casanova JL, Puel A.

J Exp Med. 2020 Jun 1;217(6). pii: e20191804. doi: 10.1084/jem.20191804.

PMID:
32207811
2.

Unprecedentedly High Dust Ingestion Estimates for the General Population in a Mining District of DR Congo.

Smolders E, Roels L, Kuhangana TC, Coorevits K, Vassilieva E, Nemery B, Lubaba Nkulu CB.

Environ Sci Technol. 2019 Jul 2;53(13):7851-7858. doi: 10.1021/acs.est.9b01973. Epub 2019 Jun 11.

PMID:
31149816
3.

A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive TH17 immunity.

De Bruyne M, Bogaert DJ, Venken K, Van den Bossche L, Bonroy C, Roels L, Tavernier SJ, van de Vijver E, Driessen A, van Gijn M, Gámez-Diaz L, Elewaut D, Grimbacher B, Haerynck F, Moes N, Dullaers M.

J Allergy Clin Immunol. 2018 Dec;142(6):1968-1971. doi: 10.1016/j.jaci.2018.08.026. Epub 2018 Sep 5. No abstract available.

PMID:
30193839
4.

Potential for deceased donation not optimally exploited: donor action data from six countries.

Roels L, Smits J, Cohen B.

Transplantation. 2012 Dec 15;94(11):1167-71. doi: 10.1097/TP.0b013e31826dde40.

PMID:
23114533
5.

Worldwide variability in deceased organ donation registries.

Rosenblum AM, Li AH, Roels L, Stewart B, Prakash V, Beitel J, Young K, Shemie S, Nickerson P, Garg AX.

Transpl Int. 2012 Aug;25(8):801-11. doi: 10.1111/j.1432-2277.2012.01472.x. Epub 2012 Apr 16. Review.

6.

The European experience.

Roels L, Rahmel A.

Transpl Int. 2011 Apr;24(4):350-67. doi: 10.1111/j.1432-2277.2011.01225.x. Epub 2011 Jan 26. Review.

7.

Critical Care staffs' attitudes, confidence levels and educational needs correlate with countries' donation rates: data from the Donor Action database.

Roels L, Spaight C, Smits J, Cohen B.

Transpl Int. 2010 Aug;23(8):842-50. doi: 10.1111/j.1432-2277.2010.01065.x. Epub 2010 Mar 1.

8.

Donation patterns in four European countries: data from the donor action database.

Roels L, Spaight C, Smits J, Cohen B.

Transplantation. 2008 Dec 27;86(12):1738-43. doi: 10.1097/TP.0b013e3181908e08.

PMID:
19104414
9.

Donation after uncontrolled cardiac death (uDCD): a review of the debate from a European perspective.

Borry P, Van Reusel W, Roels L, Schotsmans P.

J Law Med Ethics. 2008 Winter;36(4):752-9, 610. doi: 10.1111/j.1748-720X.2008.00334.x. Review.

PMID:
19094003
10.

An analysis of critical care staff's attitudes to donation in a country with presumed-consent legislation.

Pelleriaux B, Roels L, Van Deynse D, Smits J, Cornu O, Delloye C.

Prog Transplant. 2008 Sep;18(3):173-8. Erratum in: Prog Transplant. 2008 Dec;18(4):231.

PMID:
18831482
11.

Countries' donation performance in perspective: time for more accurate comparative methodologies.

Roels L, Cohen B, Gachet C.

Am J Transplant. 2007 Jun;7(6):1439-41. No abstract available.

12.

Waiting for a thoracic transplant in Eurotransplant.

Smits JM, Vanhaecke J, Haverich A, de Vries E, Roels L, Persijn G, Laufer G.

Transpl Int. 2006 Jan;19(1):54-66.

13.

Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives.

Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M.

Am J Transplant. 2004 Apr;4(4):569-73.

14.

Joining efforts in tackling the organ shortage: the Donor Action experience.

Roels L, Cohen B, Gachet C, Miranda BS.

Clin Transpl. 2002:111-20.

PMID:
12971440
15.

Nonexploited potential for organ donation: donor action pre intervention data and the Polish case.

Roels L, Patrzalek D, Cohen B, Gachet C, Wight C.

Transplant Proc. 2003 May;35(3):1159-62. No abstract available.

PMID:
12947894
16.

Cost-benefit approach in evaluating investment into donor action: the German case.

Roels L, Kalo Z, Boesebeck D, Whiting J, Wight C.

Transpl Int. 2003 May;16(5):321-6. Epub 2003 Mar 1.

PMID:
12759723
17.

How to improve organ donation: results of the ISHLT/FACT poll.

Oz MC, Kherani AR, Rowe A, Roels L, Crandall C, Tomatis L, Young JB.

J Heart Lung Transplant. 2003 Apr;22(4):389-410.

PMID:
12681417
18.

Donor Action: an international initiative to alleviate organ shortage.

Roels L, Wight C.

Prog Transplant. 2001 Jun;11(2):90-7. Erratum in: Prog Transplant 2001 Dec;11(4):244.

PMID:
11871052
19.

Effect of triiodothyronine replacement therapy on maintenance characteristics and organ availability in hemodynamically unstable donors.

Roels L, Pirenne J, Delooz H, Lauwers P, Vandermeersch E.

Transplant Proc. 2000 Nov;32(7):1564-6. No abstract available.

PMID:
11119835
20.

Impact of early vesico ureteral reflux on the transplanted kidney.

Coosemans W, Rega F, Roels L, Peeters J, Donck J, Vanwalleghem J, Maes B, Vanrenterghem Y, Pirenne J.

Transplant Proc. 1999 Feb-Mar;31(1-2):362-4. No abstract available.

PMID:
10083143

Supplemental Content

Support Center